Petros Pharmaceuticals, Inc. (PTPI) Revenue 2020–2024
Petros Pharmaceuticals, Inc. (PTPI) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$5.1MFY2024 · since FY2020: $9.6M → $5.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $5.1M | -12.2% |
| FY2023 | $5.8M | -2.8% |
| FY2022 | $6.0M | -23.3% |
| FY2021 | $7.8M | -18.3% |
| FY2020 | $9.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PTPI financial trends
PTPI Net incomePTPI Net marginPTPI Gross profitPTPI Gross marginPTPI Operating incomePTPI Operating marginPTPI Operating cash flowPTPI Free cash flowPTPI Capital expendituresPTPI Return on equityPTPI Stock buybacksPTPI Dividends paidPTPI Total assetsPTPI Total liabilitiesPTPI Shareholders’ equityPTPI overview →